| Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) -> Monitor Keywords |
|
Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)USPTO Application #: 20070173455Title: Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) Abstract: In one embodiment, this invention provides an antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting essentially of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP. In another embodiment, this invention provides a method of preventing and treating obesity and non-insulin dependent diabetes mellitus (Type II) in a patient comprising administering to the patient an antagonist of glucose-dependent insulinotropic polypeptide (GIP). In yet another embodiment, this invention provides a method of improving glucose tolerance in a mammal comprising administering to the mammal an antagonist of glucose-dependent insulinotropic polypeptide (GIP). (end of abstract) USPTO Applicaton #: 20070173455 - Class: 514013000 (USPTO) Related Patent Categories: Drug, Bio-affecting And Body Treating Compositions, Designated Organic Active Ingredient Containing (doai), Peptide Containing (e.g., Protein, Peptones, Fibrinogen, Etc.) Doai, Cyclopeptides, 16 To 24 Peptide Repeating Units In Known Peptide Chain
Click on the above for other options relating to this Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) patent application. ### 1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored. 3. Each week you receive an email with patent applications related to your keywords. Start now! - Receive info on patent apps like Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) or other areas of interest. ### Previous Patent Application: Preptin fragments and methods of use Next Patent Application: Tau-conotoxin peptides Industry Class: Drug, bio-affecting and body treating compositions ### FreshPatents.com Support Thank you for viewing the Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) patent info. IP-related news and info Results in 0.04792 seconds Other interesting Feshpatents.com categories: Novartis , Pfizer , Philips , Polaroid , Procter & Gamble , |
|||